Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: zeta1961 who wrote (909)	4/12/2005 4:19:06 PM
From: Jibacoa	Read Replies (2) \| Respond to of 3722

Re: INGN, down 9% last I checked post Rodman/Renshaw downgrade. Yes, it was downgraded by R & R which have a good history of predicting INGN's and a few others stocks future course.<g> Back in September 2003 they initiated they "cover" on INGN when the stock was at $11.20 with a "predictive rating" of "Mkt Outperform" and by the end of November that year the stock was down to $5.95 ( just a 47% drop in two months.<g>) Then in June 2004 they "downgraded" it when it was at $4.50 changing their rating from "Mkt Outperform" to "Mkt Perform" and by December that year the stock was up to $9.80 (just an 118% gain in 6 months.<g>) Now they downgraded it, and their clients who sold the stock today at $7.05 will be happy when the ASCO meeting starts on Friday May 13th looking at the stock price, which R & R expects that it will be going down since it is a "bad luck Friday".<g> As you can see from their previous "predictions", their record is very good and this one could be one of their best.<g> RAGL Bernard